| 201 |
11099323 | p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma. | 2000 Dec 1 |
3 |
| 202 |
11129289 | Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. | 2000 Nov |
1 |
| 203 |
11175336 | Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis. | 2000 Dec 14 |
1 |
| 204 |
11205220 | p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen. | 2000 Nov-Dec |
2 |
| 205 |
11899648 | A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923. | 2000 Oct |
1 |
| 206 |
10210535 | Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor. | 1999 Apr |
2 |
| 207 |
10210540 | Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. | 1999 Apr |
1 |
| 208 |
10347252 | Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein. | 1999 Jun |
1 |
| 209 |
10421546 | Paclitaxel sensitivity correlates with p53 status and DNA fragmentation, but not G2/M accumulation. | 1999 Jul 15 |
7 |
| 210 |
10424768 | Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells. | 1999 Aug 1 |
1 |
| 211 |
10446979 | DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4. | 1999 Aug 1 |
1 |
| 212 |
10453723 | Failure of taxol-based combination chemotherapy for malignant glioma cannot be overcome by G2/M checkpoint abrogators or altering the p53 status. | 1999 |
2 |
| 213 |
10471519 | Molecular effects of paclitaxel: myths and reality (a critical review). | 1999 Oct 8 |
2 |
| 214 |
10534572 | Molecular effects of taxol and caffeine on pancreatic cancer cells. | 1999 Nov |
1 |
| 215 |
10554637 | Radiochemotherapy with paclitaxel: synchronization effects and the role of p53. | 1999 Oct |
1 |
| 216 |
10665656 | Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways. | 1999 Dec |
1 |
| 217 |
10697517 | Effect of paclitaxel pretreatment on radiation-induced p53-dependent apoptosis. | 1999 Nov-Dec |
3 |
| 218 |
9472635 | Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. | 1998 |
2 |
| 219 |
9563876 | Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer. | 1998 Apr |
3 |
| 220 |
9563901 | Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment. | 1998 Apr |
3 |
| 221 |
9584207 | Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. | 1998 May |
4 |
| 222 |
9633517 | Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis. | 1998 May 25 |
5 |
| 223 |
9636834 | Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol. | 1998 Apr |
6 |
| 224 |
9661042 | Evidence of p53-induced apoptosis in cancer cells exposed to taxol. | 1998 Jun |
1 |
| 225 |
9703286 | Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status. | 1998 Aug |
2 |
| 226 |
9772293 | Cell cycle arrest in ovarian cancer cell lines does not depend on p53 status upon treatment with cytostatic drugs. | 1998 Nov |
3 |
| 227 |
9792903 | Paclitaxel and concurrent radiation for locally advanced pancreatic carcinoma. | 1998 Nov 1 |
1 |
| 228 |
9865905 | Relationship between paclitaxel activity and pathobiology of human solid tumors. | 1998 Dec |
2 |
| 229 |
9865921 | CDK4 down-regulation induced by paclitaxel is associated with G1 arrest in gastric cancer cells. | 1998 Dec |
1 |
| 230 |
9041188 | p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. | 1997 Mar 1 |
3 |
| 231 |
9108094 | Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts. | 1997 Apr 15 |
3 |
| 232 |
9206986 | Weekly paclitaxel as a radiation sensitizer for locally advanced gastric and pancreatic cancers: the Brown University Oncology Group experience. | 1997 May 1 |
1 |
| 233 |
9815592 | Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism. | 1997 Nov |
1 |
| 234 |
8564846 | Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. | 1996 Jan |
4 |
| 235 |
8763853 | The interaction of taxol and vinblastine with radiation induction of p53 and p21 WAF1/CIP1. | 1996 Jul |
3 |
| 236 |
8826941 | p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma. | 1996 Sep 15 |
3 |
| 237 |
8943066 | BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. | 1996 Nov 26 |
1 |
| 238 |
7553639 | Taxol induction of p21WAF1 and p53 requires c-raf-1. | 1995 Oct 15 |
9 |
| 239 |
8521300 | LPS and Taxol activate Lyn kinase autophosphorylation in Lps(n), but not in Lpsd), macrophages. | 1995 May |
1 |
| 240 |
8521385 | Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. | 1995 Dec 15 |
3 |